Carbachol
- Generic Name
- Carbachol
- Brand Names
- Carbastat, Miostat
- Drug Type
- Small Molecule
- Chemical Formula
- C6H15N2O2
- CAS Number
- 462-58-8
- Unique Ingredient Identifier
- 54Z8M50D6Q
- Background
Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932. Carbamoylcholine was initially used as a treatment for migraines, induction of diuresis, and other parasympathetic effects.
Carbamoylcholine was granted FDA approval on 28 September 1972.
- Indication
Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.
- Associated Conditions
- Acute angle-closure glaucoma, Increased Intra Ocular Pressure (IOP), Open Angle Glaucoma (OAG)
- Associated Therapies
- -
Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- Visus Therapeutics
- Target Recruit Count
- 81
- Registration Number
- NCT04774237
- Locations
- 🇺🇸
Total Eye Care, PA, Memphis, Tennessee, United States
🇺🇸Global Research Management, Inc., Glendale, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
Carbachols Headache-inducing Effect and Changes in Cerebral Blood Flow in Migraine Patients
- First Posted Date
- 2007-11-28
- Last Posted Date
- 2009-08-03
- Lead Sponsor
- Danish Headache Center
- Target Recruit Count
- 12
- Registration Number
- NCT00564408
- Locations
- 🇩🇰
Danish Headache Center, Glostrup, Denmark
Carbachol´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
- Conditions
- First Posted Date
- 2006-07-28
- Last Posted Date
- 2007-08-30
- Lead Sponsor
- Danish Headache Center
- Target Recruit Count
- 15
- Registration Number
- NCT00357864
- Locations
- 🇩🇰
Dansih Headache Center, Glostrup, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.